Eight Sleep just closed a $100 million Series D funding round, bringing total capital raised to $260 million as the AI-powered sleep tech company eyes unicorn status. The round attracted top-tier investors including Valor Equity Partners, Founders Fund, and Formula 1 personalities Charles Leclerc and Zak Brown, signaling mainstream confidence in the booming sleep wellness market.
Eight Sleep just made the biggest bet yet on AI-powered sleep technology, closing a $100 million Series D that brings the New York startup's total funding to $260 million. The round signals massive institutional confidence in a company that's already generated over $500 million in sales from its smart mattress technology.
The funding comes from an impressive roster including HSG, Valor Equity Partners, Founders Fund, and Y Combinator, alongside Formula 1 personalities Ferrari driver Charles Leclerc and McLaren CEO Zak Brown. The athlete involvement isn't just celebrity endorsement – it reflects Eight Sleep's deep penetration into performance optimization markets where sleep recovery directly impacts million-dollar careers.
"If we successfully execute our AI roadmap, launch internationally, and develop condition-specific interventions, achieving unicorn status will naturally follow," co-founder and CMO Alexandra Zatarain told TechCrunch. The company's current valuation remains undisclosed, but it previously hit a $500 million post-money valuation in its 2021 Series C.
Eight Sleep's timing couldn't be better. With roughly one in three U.S. adults getting insufficient sleep, the sleep tech market has exploded into a multi-billion dollar opportunity. The company's flagship Pod mattress uses embedded sensors to track sleep stages, heart rate, breathing patterns, and movement, then automatically adjusts temperature, elevation, and firmness in real-time.
What sets Eight Sleep apart from wearable competitors like Oura, Fitbit, and Apple Watch is its contactless approach. The company has collected insights from over one billion hours of sleep data without requiring users to wear anything, positioning it uniquely as consumers grow weary of device fatigue.
The company's revenue has expanded tenfold since launching the Pod in 2019, with just over 100 employees generating half-a-billion in sales – a remarkably lean operation for such scale. Now Eight Sleep is pushing beyond hardware into AI-driven health interventions with its new Sleep Agent system that leverages large language models to create thousands of digital twins for each user.
"This approach shifts sleep technology from reactive tracking to proactive, personalized intervention," Zatarain explained. The company's Autopilot feature "builds a personal blueprint from night one, then adapts continuously, accounting for seasonality, travel, stress, training, illness, or even a bad night before."
The medical expansion represents Eight Sleep's biggest growth opportunity. Its new Health Check system monitors cardiovascular and respiratory patterns with up to 99% accuracy, potentially competing with medical device companies like ResMed. The company recently launched Hot Flash Mode for menopause symptom relief and is pursuing FDA approval for contactless sleep apnea solutions.
"We're not replacing your doctor, but we are giving you nightly, high-accuracy health monitoring so you can act early if trends shift," Zatarain said, positioning Eight Sleep at the intersection of consumer wellness and preventive healthcare.
International expansion is accelerating, with the company already shipping to over 30 countries including Canada, the UK, EU nations, Australia, Mexico, and the UAE. China represents the next major market, where Zatarain notes "a rise in a health-conscious middle class that prioritizes sleep and overall wellness."
The competitive landscape remains intense. Traditional mattress companies like Sleep Number and ChiliSleep offer smart sleep surfaces, while tech giants push wearable solutions. Eight Sleep's contactless, AI-driven approach and medical ambitions could prove the winning formula in a market where personalization and health outcomes increasingly drive purchase decisions.
Eight Sleep's $100 million Series D validates the massive opportunity in AI-powered health monitoring, particularly as the company expands from consumer wellness into regulated medical applications. With proven revenue scale, international expansion momentum, and a clear path toward unicorn valuation, Eight Sleep is positioning itself as the definitive player in intelligent sleep technology. The real test will be whether its contactless, AI-driven approach can capture market share from entrenched wearable competitors and traditional medical device companies as sleep wellness becomes increasingly medicalized.
